The HEMASHIELD grafts are the most used, most studied vascular products available in the market today. More than 2 million HEMASHIELD grafts have been implanted worldwide, demonstrating clinical ...

The MAQUET line of FUSION grafts Graft merges ePTFE with PET, creating a completely new concept for peripheral vascular procedures. It delivers the easy handling of ePTFE with the reduced suture ...

Cite this: Technology Insight: The Evolution of Tissue-Engineered Vascular Grafts--From Research to Clinical Practice - Medscape - Jul 01, 2007. The recent transition to clinical use by two ...

A breakthrough in life-saving medical technology has arrived. The U.S. Food and Drug Administration (FDA) has officially ...

The single-use product is surgically implanted for arterial replacement and repair after a traumatic injury to the extremity.

The FDA on Friday approved acellular tissue engineered vessel (Symvess), an off-the-shelf product for treating vascular ...

SYMVESS is a bioengineered human tissue designed as a vascular conduit for arterial replacement in adults facing imminent limb loss. How does SYMVESS compare to traditional vein grafts?

Silver Spring, Md Thursday, December 26, 2024, 11:00 Hrs [IST] ...

Lake Street analyst Frank Takkinen reiterated a Buy rating on Lemaitre Vascular (LMAT – Research Report) today and set a price target of ...